Results of a multicenter phase II trial for older patients with c-Kit-positive acute myeloid leukemia (AML) and high-risk myelodysplastic syndrome (HR-MDS) using low-dose Ara-C and Imatinib

Cancer ◽  
2007 ◽  
Vol 109 (5) ◽  
pp. 907-914 ◽  
Author(s):  
Florian Heidel ◽  
Jorge Cortes ◽  
Frank G. Rücker ◽  
Walter Aulitzky ◽  
Laurie Letvak ◽  
...  
Keyword(s):  
Acute Myeloid Leukemia ◽  
High Risk ◽  
Myelodysplastic Syndrome ◽  
Phase Ii ◽  
Older Patients ◽  
Myeloid Leukemia ◽  
Low Dose ◽  
Phase Ii Trial ◽  
Multicenter Phase ◽  
Acute Myeloid

scholarly journals Randomized comparison of low dose cytarabine with or without glasdegib in patients with newly diagnosed acute myeloid leukemia or high-risk myelodysplastic syndrome

Leukemia ◽  
2018 ◽  
Vol 33 (2) ◽  
pp. 379-389 ◽  
Author(s):  
Jorge E. Cortes ◽  
Florian H. Heidel ◽  
Andrzej Hellmann ◽  
Walter Fiedler ◽  
B. Douglas Smith ◽  
...  
Keyword(s):  
Acute Myeloid Leukemia ◽  
High Risk ◽  
Myelodysplastic Syndrome ◽  
Myeloid Leukemia ◽  
Low Dose ◽  
Newly Diagnosed ◽  
Low Dose Cytarabine ◽  
Acute Myeloid

Phase II trial of CPX-351 in patients with acute myeloid leukemia at high risk for induction mortality

Leukemia ◽  
2020 ◽  
Vol 34 (11) ◽  
pp. 2914-2924
Author(s):  
Ghayas C. Issa ◽  
Hagop M. Kantarjian ◽  
Lianchun Xiao ◽  
Jing Ning ◽  
Yesid Alvarado ◽  
...  
Keyword(s):  
Acute Myeloid Leukemia ◽  
High Risk ◽  
Phase Ii ◽  
Myeloid Leukemia ◽  
Phase Ii Trial ◽  
Acute Myeloid

Phase I/II study of vosaroxin and decitabine in older patients (pts) with acute myeloid leukemia (AML) and high-risk myelodysplastic syndrome (MDS).

2014 ◽  
Vol 32 (15_suppl) ◽  
pp. 7098-7098
Author(s):  
Naval Guastad Daver ◽  
Hagop M. Kantarjian ◽  
Sherry Pierce ◽  
Mark Brandt ◽  
Courtney Denton Dinardo ◽  
...  
Keyword(s):  
Acute Myeloid Leukemia ◽  
High Risk ◽  
Myelodysplastic Syndrome ◽  
Phase I ◽  
Older Patients ◽  
Myeloid Leukemia ◽  
Acute Myeloid

scholarly journals Vosaroxin in combination with decitabine in newly diagnosed older patients with acute myeloid leukemia or high-risk myelodysplastic syndrome

Haematologica ◽  
2017 ◽  
Vol 102 (10) ◽  
pp. 1709-1717 ◽  
Author(s):  
Naval Daver ◽  
Hagop Kantarjian ◽  
Guillermo Garcia-Manero ◽  
Elias Jabbour ◽  
Gautam Borthakur ◽  
...  
Keyword(s):  
Acute Myeloid Leukemia ◽  
High Risk ◽  
Myelodysplastic Syndrome ◽  
Older Patients ◽  
Myeloid Leukemia ◽  
Newly Diagnosed ◽  
Acute Myeloid
Sign in / Sign up

Export Citation Format

Share Document